SHINE Technologies

Ilumira authorization opens EU route for SHINE Lu-177

The EMA-authorized radiopharmaceutical precursor is produced at SHINE’s Cassiopeia facility in Wisconsin for use in radiolabelling carrier medicines.

RadiologySignal.com writers·May 29, 2026